Quarterly report pursuant to Section 13 or 15(d)

CONDENSED INTERIM STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (unaudited)

v3.24.1.1.u2
CONDENSED INTERIM STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (unaudited) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at beginning at Dec. 31, 2022 $ 11,628 $ 45,944,478 $ (38,641,085) $ 7,315,021
Balance at beginning, Common shares (in shares) at Dec. 31, 2022 11,627,609      
Share-Based Compensation   733,472   733,472
Share-Based Payments to Vendors $ 44 165,859   165,903
Share-Based Payments to Vendors (in shares) 44,186      
Net Income (Loss)     (2,902,957) (2,902,957)
Balance at ending at Mar. 31, 2023 $ 11,672 46,843,809 (41,544,042) 5,311,439
Balance at ending, Common shares (in shares) at Mar. 31, 2023 11,671,795      
Balance at beginning at Dec. 31, 2023 $ 14,468 57,871,070 (53,218,853) $ 4,666,685
Balance at beginning, Common shares (in shares) at Dec. 31, 2023 14,468,229     14,468,229
Share-Based Compensation   894,523   $ 894,523
Share-Based Payments to Vendors $ 90 305,510   305,600
Share-Based Payments to Vendors (in shares) 90,000      
Issuance of shares of common stock in At-the-Market sales agreement, net of $135,741 cash issuance costs $ 1,140 4,298,334   4,299,474
Issuance of shares of common stock in At-the-Market sales agreement, net of $135,741 cash issuance costs (in shares) 1,139,662      
Warrant Exercise $ 59 210,140   210,199
Warrant Exercise (in shares) 59,211      
Net Income (Loss)     (4,377,889) (4,377,889)
Balance at ending at Mar. 31, 2024 $ 15,757 $ 63,579,577 $ (57,596,742) $ 5,998,592
Balance at ending, Common shares (in shares) at Mar. 31, 2024 15,757,102     15,757,102